Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Current prospects and future challenges for nasal vaccine delivery.

Yusuf H, Kett V.

Hum Vaccin Immunother. 2017 Jan 2;13(1):34-45. doi: 10.1080/21645515.2016.1239668. Epub 2016 Dec 9.

PMID:
27936348
2.

2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in Atherosclerosis.

Ley K.

Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):429-38. doi: 10.1161/ATVBAHA.115.306009. Epub 2016 Jan 28.

3.

Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance.

Park AC, Huang G, Jankowska-Gan E, Massoudi D, Kernien JF, Vignali DA, Sullivan JA, Wilkes DS, Burlingham WJ, Greenspan DS.

J Biol Chem. 2016 Feb 12;291(7):3359-70. doi: 10.1074/jbc.M115.681882. Epub 2015 Dec 31.

4.

Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.

Zhong Y, Tang H, Wang X, Zeng Q, Liu Y, Zhao XI, Yu K, Shi H, Zhu R, Mao X.

Clin Exp Immunol. 2016 Mar;183(3):452-68. doi: 10.1111/cei.12726. Epub 2015 Nov 24.

5.

Preventive Activity against Influenza (H1N1) Virus by Intranasally Delivered RNA-Hydrolyzing Antibody in Respiratory Epithelial Cells of Mice.

Cho S, Youn HN, Hoang PM, Cho S, Kim KE, Kil EJ, Lee G, Cho MJ, Hong J, Byun SJ, Song CS, Lee S.

Viruses. 2015 Sep 21;7(9):5133-44. doi: 10.3390/v7092863.

6.

Beyond vascular inflammation--recent advances in understanding atherosclerosis.

Wolf D, Zirlik A, Ley K.

Cell Mol Life Sci. 2015 Oct;72(20):3853-69. doi: 10.1007/s00018-015-1971-6. Epub 2015 Jun 23. Review.

7.

Cholera toxin B: one subunit with many pharmaceutical applications.

Baldauf KJ, Royal JM, Hamorsky KT, Matoba N.

Toxins (Basel). 2015 Mar 20;7(3):974-96. doi: 10.3390/toxins7030974. Review.

8.

Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment.

Garetto S, Trovato AE, Lleo A, Sala F, Martini E, Betz AG, Norata GD, Invernizzi P, Kallikourdis M.

Immunobiology. 2015 Aug;220(8):1025-9. doi: 10.1016/j.imbio.2015.02.006. Epub 2015 Feb 26.

9.

Vaccination to modulate atherosclerosis.

Kimura T, Tse K, Sette A, Ley K.

Autoimmunity. 2015 May;48(3):152-60. doi: 10.3109/08916934.2014.1003641. Epub 2015 Feb 16. Review.

10.

Inflammation and immunity in diseases of the arterial tree: players and layers.

Libby P, Hansson GK.

Circ Res. 2015 Jan 16;116(2):307-11. doi: 10.1161/CIRCRESAHA.116.301313. Review.

11.

Treating atherosclerosis with regulatory T cells.

Foks AC, Lichtman AH, Kuiper J.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):280-7. doi: 10.1161/ATVBAHA.114.303568. Epub 2014 Nov 20. Review.

12.

The role of T and B cells in human atherosclerosis and atherothrombosis.

Ammirati E, Moroni F, Magnoni M, Camici PG.

Clin Exp Immunol. 2015 Feb;179(2):173-87. doi: 10.1111/cei.12477. Review.

13.

Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects.

Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV.

Front Physiol. 2014 May 27;5:196. doi: 10.3389/fphys.2014.00196. eCollection 2014. Review.

14.

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases.

Chyu KY, Shah PK.

Ther Adv Vaccines. 2014 Mar;2(2):56-66. doi: 10.1177/2051013613514327. Review.

15.

Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes.

Klingenberg R, Brokopp CE, Grivès A, Courtier A, Jaguszewski M, Pasqual N, Vlaskou Badra E, Lewandowski A, Gaemperli O, Hoerstrup SP, Maier W, Landmesser U, Lüscher TF, Matter CM.

Eur Heart J. 2015 May 1;36(17):1041-8. doi: 10.1093/eurheartj/eht543. Epub 2014 Jan 12.

16.

Downregulation of CD4+LAP+ and CD4+CD25+ regulatory T cells in acute coronary syndromes.

Lin YZ, Lu SH, Lu ZD, Huang Y, Shi Y, Liu L, Wang XY, Ji QW.

Mediators Inflamm. 2013;2013:764082. doi: 10.1155/2013/764082. Epub 2013 Dec 10.

18.

Regulatory T cells and Atherosclerosis.

Pastrana JL, Sha X, Virtue A, Mai J, Cueto R, Lee IA, Wang H, Yang XF.

J Clin Exp Cardiolog. 2012 Oct 8;2012(Suppl 12):2.

19.

Treg inducing adjuvants for therapeutic vaccination against chronic inflammatory diseases.

Keijzer C, van der Zee R, van Eden W, Broere F.

Front Immunol. 2013 Aug 20;4:245. doi: 10.3389/fimmu.2013.00245. eCollection 2013.

20.

The influence of innate and adaptive immune responses on atherosclerosis.

Witztum JL, Lichtman AH.

Annu Rev Pathol. 2014;9:73-102. doi: 10.1146/annurev-pathol-020712-163936. Epub 2013 Aug 7. Review.

Supplemental Content

Support Center